サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1594984

ビタミンD療法の世界市場

Vitamin D Therapy

出版日
ページ情報
英文 92 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
ビタミンD療法の世界市場
出版日: 2024年11月22日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 92 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ビタミンD療法の世界市場は2030年までに86億米ドルに到達

2023年に40億米ドルと推定されるビタミンD療法の世界市場は、分析期間2023-2030年にCAGR 11.5%で成長し、2030年には86億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである経口投与は、CAGR 11.9%を記録し、分析期間終了時には59億米ドルに達すると予測されます。非経口投与セグメントの成長率は、分析期間中CAGR 10.8%と推定されます。

米国市場は11億米ドルと推定、中国はCAGR 10.8％で成長予測

米国のビタミンD療法市場は2023年に11億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに13億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは10.8%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ10.0％と9.6％と予測されています。欧州では、ドイツがCAGR 8.3%で成長すると予測されています。

世界のビタミンD療法市場- 主要動向と促進要因まとめ

ビタミンD療法とは何か、なぜ現代ヘルスケアにおいて重要なのか？

ビタミンD療法とは、ビタミンD欠乏症や関連する健康状態を予防・治療するためのビタミンDサプリメントや医薬品の医療用使用を指します。ビタミンDはカルシウムの吸収、骨の健康、免疫機能、骨粗鬆症、くる病、心血管疾患、自己免疫疾患などの様々な疾患の予防に重要な役割を果たす重要な栄養素です。ビタミンD療法には、市販のサプリメント、処方グレードのビタミンD（ビタミンD2やD3など）、高用量の注射などがあり、ビタミンD濃度が低い人、欠乏症のリスクがある人、慢性腎臓病、骨粗鬆症、吸収不良症候群などの特定の疾患を持つ患者によく処方されます。

ビタミンD療法の重要性は、世界的に数百万人が罹患しており、骨が弱くなり、骨折のリスクが高まり、免疫機能が低下し、その他の健康問題を引き起こす可能性のあるビタミンD欠乏症に対処する能力にあります。ビタミンD療法は、骨の健康、免疫サポート、炎症コントロールに不可欠な役割を果たすことから、骨粗鬆症のような症状の管理、高齢者の転倒リスクの軽減、健康全般のサポートに欠かせません。ビタミンDが呼吸器感染症の重症度を軽減したり、精神的な健康をサポートしたりするなど、より広範な効果があることが調査で明らかになりつつあり、ビタミンD療法は予防と治療の両面でヘルスケア戦略の要となっています。

技術の進歩はビタミンD療法市場をどのように形成しているか？

技術の進歩は、ビタミンD療法の有効性、精度、アクセシビリティを大幅に向上させ、ヘルスケア分野全体のイノベーションを促進しています。主要な開発の一つは、リポソーム型ビタミンD、ナノエマルジョン、舌下スプレーなど、より生物学的に利用しやすい製剤の台頭です。これらの高度な送達システムは、ビタミンDの生物学的利用能を高め、消化器系をバイパスして血流に直接吸収されるようにし、吸収のばらつきを減少させる。これは、吸収不良の患者や欠乏症の迅速な改善を必要とする患者にとって特に有益です。

ビタミンD濃度の診断検査の進歩も、市場の形成に重要な役割を果たしています。高度なイムノアッセイや質量分析計を含む高精度の検査法は、血清25-ヒドロキシビタミンD濃度を正確に測定することができるため、ヘルスケアプロバイダーは個々のニーズに合わせた治療を行うことができます。迅速なポイントオブケア検査により、臨床医はビタミンD欠乏症のスクリーニングやビタミンD投与量の調整をより効果的に行えるようになり、個別化された治療計画を支援できるようになった。モバイルアプリやウェアラブルデバイスなどのデジタルヘルス技術は、ビタミンD摂取量、日光浴、健康全般の転帰を追跡する機能を提供するようになり、患者は治療やコンプライアンスをより効果的にモニタリングできるようになった。

ビタミンD療法と遠隔医療との統合は、特に遠隔地や十分なサービスを受けていない地域でのアクセスをさらに拡大しました。テレヘルスプラットフォームにより、ヘルスケアプロバイダーは、バーチャルな診察を通じて、欠乏症の診断、サプリメントの処方、患者の経過観察を行うことができ、ビタミンD療法をより多くの人々が利用できるようになりました。さらに、AIを活用した健康分析により、患者の人口統計、食習慣、地理的位置、ライフスタイル要因に基づいてビタミンD欠乏症が予測され、予防的介入やより的を絞った治療が支援されるようになっています。このような技術革新は、ビタミンD療法の機能を拡大するだけでなく、現代の医療システムにおける個別化医療、デジタルヘルスケア、予防医療といった幅広い動向にも合致しています。

さまざまな健康状態におけるビタミンD療法の新たな応用例とは？

ビタミンD療法は、骨の健康、免疫機能、そして健康全般をサポートするという重要な役割を担っているため、様々な健康状態への応用が広がっています。骨粗鬆症や骨の健康管理において、ビタミンD療法は特に高齢者や閉経後の女性において、カルシウムの吸収を改善し、骨密度を高め、骨折のリスクを減らすために使用される標準的な治療法です。骨の健康を最適化し、骨減少症が骨粗鬆症に進行するのを防ぐために、カルシウムサプリメントやビスフォスフォネートなどの薬剤と併用されることが多いです。

免疫の健康においては、ビタミンD療法は免疫反応を高め、感染症のリスクを軽減する可能性が認められています。ビタミンDが十分なレベルにあれば、インフルエンザやその他のウイルス性疾患を含む呼吸器感染症のリスクを下げることができるという研究結果があります。COVID-19の大流行時には、ビタミンDが疾患の重症度を軽減し、免疫回復力をサポートする潜在的な役割に大きな関心が寄せられ、免疫強化レジメンの一環としてビタミンDサプリメントの使用が増加しました。

糖尿病、心血管疾患、自己免疫疾患などの慢性疾患では、ビタミンD療法が全体的な健康をサポートし、疾患の進行を管理するために用いられています。調査によると、ビタミンDの欠乏は、インスリン抵抗性、高血圧、多発性硬化症などの自己免疫疾患のリスク増加と関連しています。慢性腎臓病（CKD）患者には、ビタミンD療法がミネラルと骨の障害を管理し、二次性副甲状腺機能亢進症に対処し、腎性骨異栄養症などの合併症を予防します。メンタルヘルスの分野では、ビタミンD療法はうつ症状の緩和、認知機能のサポート、高齢者の認知症リスクの低減に有望視されています。このように、ビタミンD療法は様々な健康状態に応用されており、予防ヘルスケア、慢性疾患管理、免疫サポートにおいて重要な役割を担っています。

ビタミンD療法市場の成長の原動力は？

ビタミンD療法市場の成長は、ビタミンD欠乏症に対する認識の高まり、骨粗鬆症や慢性疾患の有病率の上昇、ビタミンDの幅広い健康効果に関する研究の進展など、いくつかの要因によって牽引されています。この欠乏症の蔓延は、スクリーニング、予防的サプリメント摂取、治療介入の増加につながり、市販品と処方箋グレードのビタミンD製品に対する需要を牽引しています。

特に高齢者の間で骨粗鬆症の有病率が上昇していることが、ビタミンD療法の需要をさらに押し上げています。世界の高齢者人口が増加の一途をたどる中、ビタミンD補給を含む効果的な骨の健康管理戦略の必要性が緊急性を増しています。骨の健康に対する意識を高め、日常的なビタミンD摂取を奨励する公衆衛生上の取り組みも、市場の成長に寄与しています。ビタミンD療法を骨粗鬆症、骨減少症、骨折予防の標準治療プロトコールに組み込むことで、ビタミンDは高齢者ヘルスケアの中心的な要素となっています。

研究の進歩により、ビタミンDには免疫機能をサポートし、炎症を抑え、特定のがんや自己免疫疾患のリスクを低下させる可能性があるなど、その他の健康上の特典も明らかになってきました。こうしたエビデンスの積み重ねにより、ビタミンDは予防用サプリメントとして消費者の関心が高まり、ヘルスケアと小売の両チャネルで需要が高まっています。個別化された栄養摂取の動向も市場の成長に寄与しており、乳幼児、妊婦、アスリート、高齢者といった特定の層に合わせたビタミンDサプリメントが需要をさらに押し上げています。

生物学的に利用可能な製剤、個別化された治療アプローチ、デジタルヘルスの統合といった技術革新が進行しており、ビタミンD療法市場は力強い成長を遂げようとしています。このような動向は、一般市民の意識の高まり、予防医療への取り組み、ヘルスケア支出の増加と相まって、ビタミンD療法を、多様な人々の全体的な健康アウトカムの改善に焦点を当てた現代のヘルスケア戦略に不可欠な要素にしています。

セグメント

投与経路（経口薬、非経口薬）;方法（処方薬、OTC薬）;用途（骨粗鬆症、くる病、筋力低下、自己免疫疾患、皮膚疾患、その他の用途）

調査対象企業の例（注目の36社）

  • Abbott
  • Alkem Laboratories Ltd.
  • Cadila Healthcare Ltd.
  • GlaxoSmithKline PLC
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Torrent Pharmaceuticals Ltd.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP23048

Global Vitamin D Therapy Market to Reach US$8.6 Billion by 2030

The global market for Vitamin D Therapy estimated at US$4.0 Billion in the year 2023, is expected to reach US$8.6 Billion by 2030, growing at a CAGR of 11.5% over the analysis period 2023-2030. Oral Administration, one of the segments analyzed in the report, is expected to record a 11.9% CAGR and reach US$5.9 Billion by the end of the analysis period. Growth in the Parenteral Administration segment is estimated at 10.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.1 Billion While China is Forecast to Grow at 10.8% CAGR

The Vitamin D Therapy market in the U.S. is estimated at US$1.1 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 10.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.0% and 9.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.3% CAGR.

Global Vitamin D Therapy Market - Key Trends & Drivers Summarized

What Is Vitamin D Therapy, and Why Is It So Crucial in Modern Healthcare?

Vitamin D Therapy refers to the medical use of vitamin D supplements or medications to prevent or treat vitamin D deficiency and related health conditions. Vitamin D is a vital nutrient that plays a critical role in calcium absorption, bone health, immune function, and the prevention of various diseases, including osteoporosis, rickets, cardiovascular diseases, and autoimmune disorders. Vitamin D therapy can involve over-the-counter supplements, prescription-grade vitamin D (like vitamin D2 or D3), or high-dose injections, and it is commonly prescribed for individuals with low vitamin D levels, those at risk of deficiency, or patients with specific conditions like chronic kidney disease, osteoporosis, or malabsorption syndromes.

The importance of vitamin D therapy lies in its ability to address widespread vitamin D deficiency, which affects millions globally and can lead to weakened bones, increased risk of fractures, impaired immune function, and other health issues. Given its essential role in bone health, immune support, and inflammation control, vitamin D therapy is crucial in managing conditions like osteoporosis, reducing the risk of falls in the elderly, and supporting overall health. As research continues to reveal broader benefits of vitamin D, such as its potential role in reducing the severity of respiratory infections and supporting mental well-being, vitamin D therapy has become a cornerstone of both preventive and therapeutic healthcare strategies.

How Are Technological Advancements Shaping the Vitamin D Therapy Market?

Technological advancements have significantly enhanced the effectiveness, precision, and accessibility of Vitamin D Therapy, driving innovation across healthcare sectors. One of the major developments is the rise of more bioavailable formulations, such as liposomal vitamin D, nanoemulsions, and sublingual sprays, which improve absorption rates and increase the effectiveness of supplementation. These advanced delivery systems enhance the bioavailability of vitamin D, allowing it to be absorbed directly into the bloodstream, bypassing the digestive system and reducing variability in absorption. This is particularly beneficial for patients with malabsorption disorders or those requiring rapid correction of deficiency.

Advancements in diagnostic testing for vitamin D levels have also played a critical role in shaping the market. High-precision testing methods, including advanced immunoassays and mass spectrometry, provide accurate measurements of serum 25-hydroxyvitamin D levels, allowing healthcare providers to tailor therapy to individual needs. Rapid point-of-care testing has made it easier for clinicians to screen for deficiencies and adjust vitamin D dosages more effectively, supporting personalized treatment plans. Digital health technologies, such as mobile apps and wearable devices, now offer features for tracking vitamin D intake, sun exposure, and overall health outcomes, enabling patients to monitor their therapy and compliance more effectively.

The integration of vitamin D therapy with telemedicine has further expanded access, especially in remote or underserved areas. Telehealth platforms enable healthcare providers to diagnose deficiencies, prescribe supplements, and monitor patient progress through virtual consultations, making vitamin D therapy more accessible to a broader population. Additionally, AI-driven health analytics are being used to predict vitamin D deficiencies based on patient demographics, dietary habits, geographic location, and lifestyle factors, supporting proactive intervention and more targeted therapy. These technological innovations not only expand the capabilities of vitamin D therapy but also align with broader trends toward personalized medicine, digital healthcare, and preventive care in modern healthcare systems.

What Are the Emerging Applications of Vitamin D Therapy Across Different Health Conditions?

Vitamin D Therapy is finding expanding applications across a variety of health conditions, driven by its essential role in supporting bone health, immune function, and overall well-being. In osteoporosis and bone health management, vitamin D therapy is a standard treatment used to improve calcium absorption, enhance bone mineral density, and reduce the risk of fractures, particularly in the elderly and postmenopausal women. It is often used in combination with calcium supplements and medications like bisphosphonates to optimize bone health and prevent osteopenia from progressing to osteoporosis.

In immune health, vitamin D therapy is recognized for its potential to enhance immune responses and reduce the risk of infections. Studies have shown that adequate vitamin D levels can help lower the risk of respiratory infections, including the flu and other viral illnesses. During the COVID-19 pandemic, there was significant interest in the potential role of vitamin D in reducing disease severity and supporting immune resilience, prompting increased use of vitamin D supplements as part of immune-boosting regimens.

In chronic conditions like diabetes, cardiovascular disease, and autoimmune disorders, vitamin D therapy is used to support overall health and manage disease progression. Research indicates that vitamin D deficiency is associated with increased risks of insulin resistance, hypertension, and autoimmune diseases like multiple sclerosis. For patients with chronic kidney disease (CKD), vitamin D therapy helps manage mineral and bone disorders, addressing secondary hyperparathyroidism and preventing complications like renal osteodystrophy. In mental health, vitamin D therapy has shown promise in alleviating symptoms of depression, supporting cognitive function, and reducing the risk of dementia in older adults. The expanding applications of vitamin D therapy across these diverse health conditions highlight its critical role in preventive healthcare, chronic disease management, and immune support.

What Drives Growth in the Vitamin D Therapy Market?

The growth in the Vitamin D Therapy market is driven by several factors, including increasing awareness of vitamin D deficiency, rising prevalence of osteoporosis and chronic diseases, and growing research into the broader health benefits of vitamin D. One of the primary growth drivers is the high global prevalence of vitamin D deficiency, which affects people across all age groups, geographic locations, and socioeconomic statuses. This widespread deficiency has led to increased screening efforts, preventive supplementation, and therapeutic interventions, driving demand for both over-the-counter and prescription-grade vitamin D products.

The rising prevalence of osteoporosis, particularly among the aging population, has further fueled demand for vitamin D therapy. As the global elderly population continues to grow, the need for effective bone health management strategies, including vitamin D supplementation, has become more urgent. Public health initiatives promoting bone health awareness and encouraging routine vitamin D intake have also contributed to market growth. The integration of vitamin D therapy into standard treatment protocols for osteoporosis, osteopenia, and fracture prevention has made it a central component of geriatric healthcare.

Advancements in research have revealed additional health benefits of vitamin D, such as its potential to support immune function, reduce inflammation, and lower the risk of certain cancers and autoimmune diseases. This expanding body of evidence has increased consumer interest in vitamin D as a preventive health supplement, boosting demand in both healthcare and retail channels. The growing trend toward personalized nutrition has also contributed to market growth, with tailored vitamin D supplements designed for specific demographics, such as infants, pregnant women, athletes, and the elderly, further driving demand.

With ongoing innovations in bioavailable formulations, personalized treatment approaches, and digital health integration, the vitamin D therapy market is poised for robust growth. These trends, combined with increasing public awareness, preventive health initiatives, and rising healthcare spending, make vitamin D therapy a vital component of modern healthcare strategies focused on improving overall health outcomes across diverse populations.

SCOPE OF STUDY:

The report analyzes the Vitamin D Therapy market in terms of US$ Million by the following Application; Method; Route of Administration, and Geographic Regions/Countries:

Segments:

Route of Administration (Oral, Parenteral); Method (Prescription Drugs, OTC Drugs); Application (Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders, Skin Diseases, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 36 Featured) -

  • Abbott
  • Alkem Laboratories Ltd.
  • Cadila Healthcare Ltd.
  • GlaxoSmithKline PLC
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Torrent Pharmaceuticals Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Vitamin D Therapy - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Vitamin D Deficiency Drives Demand for Vitamin D Therapy
    • Expanding Use in Bone Health Supplements Sets the Stage for Market Growth
    • Case Overview: Demand for Vitamin D in Immune Health Enhances Market
    • Innovations in Vitamin D Fortified Foods Generate New Opportunities
    • Focus on Preventive Healthcare Boosts Adoption of Vitamin D Therapy
    • Growing Use in Osteoporosis Treatment Sustains Vitamin D Therapy Demand
    • Push for Pediatric Supplementation Drives Vitamin D Therapy Market
    • Increasing Adoption in Elderly Nutrition Enhances Vitamin D Demand
    • Expanding Application in Cardiovascular Health Drives Market Growth
    • Case Overview: Demand for Vitamin D in Prenatal Care Propels Market
    • Focus on Oral and Injectable Forms of Vitamin D Therapy Bodes Well for Growth
    • Increasing Use in Skin Health Products Drives Vitamin D Therapy Market
    • Expanding Application in Chronic Disease Management Propels Demand
    • Regulatory Push for Vitamin D Fortification Enhances Market Opportunities
    • Focus on Vitamin D Testing Increases Awareness and Boosts Market Demand
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Vitamin D Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Vitamin D Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Vitamin D Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Osteoporosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Osteoporosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Osteoporosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Rickets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Rickets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Rickets by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Muscle Weakness by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Muscle Weakness by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Muscle Weakness by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Autoimmune Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Autoimmune Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Autoimmune Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Skin Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Skin Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Skin Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Prescription Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Prescription Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Prescription Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for OTC Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for OTC Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for OTC Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Vitamin D Therapy Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Oral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Parenteral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Parenteral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Parenteral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Vitamin D Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Vitamin D Therapy by Route Of Administration - Oral and Parenteral - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Vitamin D Therapy by Route Of Administration - Oral and Parenteral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Vitamin D Therapy by Route Of Administration - Percentage Breakdown of Value Sales for Oral and Parenteral for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Vitamin D Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Vitamin D Therapy by Method - Percentage Breakdown of Value Sales for Prescription Drugs and OTC Drugs for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Vitamin D Therapy by Route Of Administration - Oral and Parenteral - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Vitamin D Therapy by Route Of Administration - Oral and Parenteral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Vitamin D Therapy by Route Of Administration - Percentage Breakdown of Value Sales for Oral and Parenteral for the Years 2014, 2024 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Vitamin D Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases for the Years 2014, 2024 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Vitamin D Therapy by Method - Percentage Breakdown of Value Sales for Prescription Drugs and OTC Drugs for the Years 2014, 2024 & 2030
  • JAPAN
    • Vitamin D Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Vitamin D Therapy by Route Of Administration - Oral and Parenteral - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Vitamin D Therapy by Route Of Administration - Oral and Parenteral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Vitamin D Therapy by Route Of Administration - Percentage Breakdown of Value Sales for Oral and Parenteral for the Years 2014, 2024 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Vitamin D Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases for the Years 2014, 2024 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Vitamin D Therapy by Method - Percentage Breakdown of Value Sales for Prescription Drugs and OTC Drugs for the Years 2014, 2024 & 2030
  • CHINA
    • Vitamin D Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Vitamin D Therapy by Route Of Administration - Oral and Parenteral - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Vitamin D Therapy by Route Of Administration - Oral and Parenteral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Vitamin D Therapy by Route Of Administration - Percentage Breakdown of Value Sales for Oral and Parenteral for the Years 2014, 2024 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for Vitamin D Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases for the Years 2014, 2024 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Vitamin D Therapy by Method - Percentage Breakdown of Value Sales for Prescription Drugs and OTC Drugs for the Years 2014, 2024 & 2030
  • EUROPE
    • Vitamin D Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Vitamin D Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Vitamin D Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Vitamin D Therapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Vitamin D Therapy by Route Of Administration - Oral and Parenteral - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Vitamin D Therapy by Route Of Administration - Oral and Parenteral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Vitamin D Therapy by Route Of Administration - Percentage Breakdown of Value Sales for Oral and Parenteral for the Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Vitamin D Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases for the Years 2014, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Vitamin D Therapy by Method - Percentage Breakdown of Value Sales for Prescription Drugs and OTC Drugs for the Years 2014, 2024 & 2030
  • FRANCE
    • Vitamin D Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Vitamin D Therapy by Route Of Administration - Oral and Parenteral - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Vitamin D Therapy by Route Of Administration - Oral and Parenteral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Vitamin D Therapy by Route Of Administration - Percentage Breakdown of Value Sales for Oral and Parenteral for the Years 2014, 2024 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for Vitamin D Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases for the Years 2014, 2024 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: France 16-Year Perspective for Vitamin D Therapy by Method - Percentage Breakdown of Value Sales for Prescription Drugs and OTC Drugs for the Years 2014, 2024 & 2030
  • GERMANY
    • Vitamin D Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Vitamin D Therapy by Route Of Administration - Oral and Parenteral - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Vitamin D Therapy by Route Of Administration - Oral and Parenteral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Vitamin D Therapy by Route Of Administration - Percentage Breakdown of Value Sales for Oral and Parenteral for the Years 2014, 2024 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Vitamin D Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases for the Years 2014, 2024 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Vitamin D Therapy by Method - Percentage Breakdown of Value Sales for Prescription Drugs and OTC Drugs for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Vitamin D Therapy by Route Of Administration - Oral and Parenteral - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Vitamin D Therapy by Route Of Administration - Oral and Parenteral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Vitamin D Therapy by Route Of Administration - Percentage Breakdown of Value Sales for Oral and Parenteral for the Years 2014, 2024 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Vitamin D Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases for the Years 2014, 2024 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Vitamin D Therapy by Method - Percentage Breakdown of Value Sales for Prescription Drugs and OTC Drugs for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Vitamin D Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Vitamin D Therapy by Route Of Administration - Oral and Parenteral - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Vitamin D Therapy by Route Of Administration - Oral and Parenteral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Vitamin D Therapy by Route Of Administration - Percentage Breakdown of Value Sales for Oral and Parenteral for the Years 2014, 2024 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Vitamin D Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases for the Years 2014, 2024 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Vitamin D Therapy by Method - Percentage Breakdown of Value Sales for Prescription Drugs and OTC Drugs for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Vitamin D Therapy by Route Of Administration - Oral and Parenteral - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Vitamin D Therapy by Route Of Administration - Oral and Parenteral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Rest of Europe 16-Year Perspective for Vitamin D Therapy by Route Of Administration - Percentage Breakdown of Value Sales for Oral and Parenteral for the Years 2014, 2024 & 2030
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Europe 16-Year Perspective for Vitamin D Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Europe 16-Year Perspective for Vitamin D Therapy by Method - Percentage Breakdown of Value Sales for Prescription Drugs and OTC Drugs for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Vitamin D Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Vitamin D Therapy by Route Of Administration - Oral and Parenteral - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Vitamin D Therapy by Route Of Administration - Oral and Parenteral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Asia-Pacific 16-Year Perspective for Vitamin D Therapy by Route Of Administration - Percentage Breakdown of Value Sales for Oral and Parenteral for the Years 2014, 2024 & 2030
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Asia-Pacific 16-Year Perspective for Vitamin D Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases for the Years 2014, 2024 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Asia-Pacific 16-Year Perspective for Vitamin D Therapy by Method - Percentage Breakdown of Value Sales for Prescription Drugs and OTC Drugs for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Vitamin D Therapy by Route Of Administration - Oral and Parenteral - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Vitamin D Therapy by Route Of Administration - Oral and Parenteral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of World 16-Year Perspective for Vitamin D Therapy by Route Of Administration - Percentage Breakdown of Value Sales for Oral and Parenteral for the Years 2014, 2024 & 2030
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of World 16-Year Perspective for Vitamin D Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases for the Years 2014, 2024 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of World 16-Year Perspective for Vitamin D Therapy by Method - Percentage Breakdown of Value Sales for Prescription Drugs and OTC Drugs for the Years 2014, 2024 & 2030

IV. COMPETITION